Morgan Stanley's stock hits an all-time high with 36% growth in 2024. Discover why experts are upgrading to Buy amid strong ...

CME (CME) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

CME Group posts strong earnings on growing trading volumes and margins. Learn the risks, market opportunities, and why it's ...

CME Group will release its second-quarter earnings later this month, and analysts anticipate a double-digit bottom-line ...

In a report released today, Patrick O’Shaughnessy from Raymond James maintained a Buy rating on CME Group, with a price target of $306.00. The company’s shares opened today at $275.00. O’Shaughnessy ...

Morgan Stanley (NYSE:MS) has named KKR & Co. Inc. (NYSE:KKR) its new top pick in the brokers, asset managers, and exchanges ...

What Happened: In a significant move reported in a Form 4 filing with the U.S. Securities and Exchange Commission on Thursday, Shepard purchased 1,146 shares of CME Group, demonstrating confidence in ...

What Happened: Maloney's recent move, as outlined in a Form 4 filing with the U.S. Securities and Exchange Commission on Thursday, involves purchasing 532 shares of CME Group. The total transaction ...

Douglas Emmett, Inc. (NYSE:DEI), a real estate investment trust (REIT), announced today that it plans to release its 2025 second quarter earnings results aft ...